Christina Reith

Christina studied at the University of Glasgow, gaining a first-class honours degree in medical biochemistry and subsequently her medical degree with honours. She completed her MRCP whilst working in the NHS and subsequently completed speciality training in Pharmaceutical Medicine in 2011. She became a Fellow of The Royal College of Physicians and Surgeons of Glasgow in 2012, and a Fellow of the Faculty of Pharmaceutical Medicine in 2013.

Since joining the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in 2004, Christina has mainly worked on large-scale clinical trials and individual participant data meta-analyses in relation to cardiovascular disease, such as those conducted by the Cholesterol Treatment Trialists’ (CTT) Collaboration, and the Antithrombotic Trialists’ (ATT) Collaboration. She has a particular research interest in the reliable assessment of drug safety using large-scale randomised data. Christina is also a keen proponent of streamlined clinical trial methodology and trials regulation. She acts as a scientific adviser to the World Health Organization and co-developed the 2024 WHO Guidance for best practices for clinical trials.

She is actively involved in supervision and training, teaching on two MSc courses, being a GMC-approved Educational Supervisor for Pharmaceutical Medicine specialty training, and acting as a college adviser for students at Green Templeton College.